4.7 Article

Posterior Hippocampal Volumes Are Associated with Remission Rates in Patients with Major Depressive Disorder

Journal

BIOLOGICAL PSYCHIATRY
Volume 64, Issue 10, Pages 880-883

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2008.06.027

Keywords

Depression; hippocampus; remission; response

Funding

  1. Canadian Institutes of Health Research (CIHR)
  2. Wyeth
  3. AstraZeneca
  4. Janssen
  5. Lilly
  6. Novartis
  7. GSK
  8. Boerhinger
  9. Oryx
  10. Lundheck
  11. CIHR
  12. Ontario Mental Health Foundation (OMHF)
  13. National Institutes of Mental Health
  14. National Alliance for Research on Schizophrenia and Depression (NARSAD)
  15. Stanley Medical Research Foundation
  16. Scotish Rite Foundation
  17. AllerGen
  18. Society of American Gastrointestinal Endoscopic Surgeons
  19. Community Health, Education, and Research Fund
  20. Regional Medical Association
  21. Center for Minimally Invasive Surgery
  22. Sanofi-Agentis (Canada)
  23. Novartis (Canada)
  24. Eli Lilly Neurosciences Foundation (Canada)
  25. St. Joseph's Healthcare Foundation

Ask authors/readers for more resources

Background: The hippocampus (HC) is smaller in patients with recurrent major depressive disorder (MDD), but few longitudinal studies have examined whether volume is associated with clinically meaningful outcomes such as response to treatment. Methods: We compared regional (head and body/tail) HC volumes in 46 patients with MDD, 14 of whom remitted after 8 weeks of first treatment to HC volumes of 32 patients who were not in remission after 8 weeks. Results: Patients who remitted had larger pretreatment hippocampal body/tail volumes bilaterally compared with those who were not in remission at 8 weeks. This difference was not apparent in either the right or left hippocampal head. Conclusions: These findings extend a small number of previous reports, suggesting that regional brain volumes might be associated with rate and extent of clinical response to antidepressant medication.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available